Your browser doesn't support javascript.
loading
Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis.
Hashimoto, Teppei; Yoshida, Kohsuke; Yokoyama, Yuichi; Hashimoto, Naonori; Kaneshiro, Kenta; Yoshikawa, Takahiro; Tateishi, Koji; Terashima, Yasuhiro; Matsui, Kiyoshi; Hashiramoto, Akira.
Afiliação
  • Hashimoto T; Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan.
  • Yoshida K; Department of Public Health, Kobe University Graduate School of Health Sciences, Kobe, Japan.
  • Yokoyama Y; Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Hashimoto N; Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan.
  • Kaneshiro K; Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan.
  • Yoshikawa T; Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan.
  • Tateishi K; Department of Orthopedics, Konan Kakogawa Hospital, Kakogawa, Japan.
  • Terashima Y; Department of Orthopedics, Konan Kakogawa Hospital, Kakogawa, Japan.
  • Matsui K; Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan.
  • Hashiramoto A; Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan.
Clin Exp Immunol ; 213(2): 209-220, 2023 07 21.
Article em En | MEDLINE | ID: mdl-37279559

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / NF-kappa B Limite: Humans Idioma: En Revista: Clin Exp Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / NF-kappa B Limite: Humans Idioma: En Revista: Clin Exp Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão